Cases 51 - 60 of 133
Sanofi-Aventis U.S. LLC et al v. Actavis LLC et al
as 1:2020cv00804
Defendant:
Hetero Labs Ltd., Belcher Pharmaceuticals, LLC, Glenmark Pharmaceuticals Ltd. and others
Plaintiff:
Sanofi Mature IP and Sanofi-Aventis U.S. LLC
Cause Of Action: 35 U.S.C. § 271
BIAL - PORTELA & CA. S.A. et al v. Hetero Labs Limited et al
as 1:2020cv00780
Plaintiff:
BIAL - PORTELA & CA. S.A., Sunovion Pharmaceuticals Inc. and Bial - Holding, S.A.
Defendant:
Hetero USA Inc., Hetero Labs Limited and Hetero Labs Limited Unit-V
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. HETERO LABS LIMITED et al
as 2:2020cv02601
Plaintiff:
CELGENE CORPORATION
Defendant:
HETERO USA, INC., HETERO LABS LIMITED, HETERO DRUGS LIMITED and others
Cause Of Action: 35 U.S.C. § 271
Gilead Sciences, Inc. v. Apotex, Inc. et al
as 1:2020cv00189
Defendant:
Macleods Pharmaceuticals Ltd., Cipla Limited, Apotex, Inc. and others
Plaintiff:
Gilead Sciences, Inc.
Cause Of Action: 35 U.S.C. § 1
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Annora Pharma Private Limited et al
as 1:2020cv00277
Defendant:
Annora Pharma Private Limited and Hetero USA Inc.,
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Apotex Inc. et al
as 1:2020cv00133
Defendant:
Bionpharma Inc., Strides Pharma, Inc., Prinston Pharmaceutical Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 1
Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc. et al
as 1:2019cv02053
Defendant:
MSN Laboratories Private Limited, Dr. Reddys Laboratories, Inc., Hetero USA Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Hetero Labs Ltd. et al
as 1:2019cv01954
Defendant:
Hetero Labs Ltd., Honour Lab Ltd., Hetero Labs Ltd. Unit-V and others
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Annora Pharma Private Limited et al
as 1:2019cv01594
Defendant:
Hetero USA Inc. and Annora Pharma Private Limited
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
